Grazia M. Vernaci

Padova, 35128, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Long-term outcome of isolated locoregional breast cancer recurrence: a large retrospective mono-institutional study.

Long-term outcome of isolated locoregional breast cancer recurrence: a large retrospective mono-institutional study.

Journal: The oncologist
Published: January 14, 2026

PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world study.

PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world study.

Journal: European journal of cancer (Oxford, England : 1990)
Published: September 09, 2025

Real-world outcomes of early-stage HER2-positive breast cancer patients treated with adjuvant paclitaxel and trastuzumab.

Real-world outcomes of early-stage HER2-positive breast cancer patients treated with adjuvant paclitaxel and trastuzumab.

Journal: NPJ breast cancer
Published: July 22, 2025

Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications.

Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications.

Journal: NPJ breast cancer
Published: May 28, 2025

Temporal evolution of breast cancer brain metastases treatments and outcomes.

Temporal evolution of breast cancer brain metastases treatments and outcomes.

Journal: NPJ breast cancer
Published: November 04, 2024

Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer.

Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 22, 2023

Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases.

Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases.

Journal: British journal of cancer
Published: September 06, 2022

Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

Journal: The oncologist
Published: August 19, 2022

Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability?

Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability?

Journal: Cancer treatment reviews
Published: July 28, 2022

Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer.

Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer.

Journal: NPJ breast cancer
Published: November 25, 2021

Gene-expression signatures to inform neoadjuvant treatment decision in HR+/HER2- breast cancer: Available evidence and clinical implications.

Gene-expression signatures to inform neoadjuvant treatment decision in HR+/HER2- breast cancer: Available evidence and clinical implications.

Journal: Cancer treatment reviews
Published: November 18, 2021

HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment.

HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment.

Journal: NPJ breast cancer
Published: November 11, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026